An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy

By D'amico A.V.   Whittington R.   Malkowicz S.B.   Loughlin K.   Schultz D.   Schnall M.   Tempany C.M.   Tomaszewski J.E.   Renshaw A.   Wein A.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 538-547

Elsevier

Access to resources Recommend Favorite

Autotransfusion Supported by Erythropoietin Therapy in Transurethral Resection of the Prostate

By Goya Nobuyuki   Toda Fusako   Nishino Seiichi   Tokumoto Tadahiko   Iguchi Yasuhiro   Kobayashi Hiroshi   Ohshima Tadashi   Kihara Takeshi   Tanabe Kazunari   Yagisawa Takashi   Nakazawa Hayakazu   Toma Hiroshi   Fujii Hisaichi   Shimizu Masaru  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 6, 1998-12 ,pp. : 383-387

Informa Healthcare

Access to resources Recommend Favorite

Erythropoietin producing cells for potential cell therapy

By Aboushwareb Tamer   Egydio Fernanda   Straker Lauren   Gyabaah Kenneth   Atala Anthony   Yoo James  

World Journal of Urology, Vol. 26, Iss. 4, 2008-08 ,pp. : 295-300

Springer Publishing Company

Access to resources Recommend Favorite

Radiolabeled Monoclonal Antibody Indium 111-Labeled CYT-356 Localizes Extraprostatic Recurrent Carcinoma After Prostatectomy - implications on the use of adjuvant therapy

By Levesque P.E.   Nieh P.T.   Zinman L.N.   Seldin D.W.   Libertino J.A.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 978-984

Elsevier

Access to resources Recommend Favorite

Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation

By Malyszko Jolanta   Malyszko Jacek   Mysliwiec Michal  

Renal Failure, Vol. 31, Iss. 7, 2009-08 ,pp. : 544-548

Informa Healthcare

Access to resources Recommend Favorite